Skip to main content
. Author manuscript; available in PMC: 2007 Sep 27.
Published in final edited form as: J Drug Target. 2006 Jun;14(5):321–329. doi: 10.1080/10611860600613316

Figure 3.

Figure 3

Anti-factor Xa activity-time profiles of ardeparin in rats after oral administration of formulations containing 1200 IU/kg of ardeparin with or without 100 μg/kg of AT1002. Data are shown as the mean concentration, and error bars represent the SEM (n = 4–6).